Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer–results from two randomised studies
…, P Rosenberg, K Boman, B Tholander… - European journal of …, 2010 - Elsevier
INTRODUCTION: Endometrial cancer patients with high grade tumours, deep myometrial
invasion or advanced stage disease have a poor prognosis. Randomised studies have …
invasion or advanced stage disease have a poor prognosis. Randomised studies have …
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and …
…, K Van Eygen, A Floquet, B Tholander… - The Lancet …, 2018 - thelancet.com
Background Individual patient data from two randomised trials comparing neoadjuvant
chemotherapy with upfront debulking surgery in advanced tubo-ovarian cancer were …
chemotherapy with upfront debulking surgery in advanced tubo-ovarian cancer were …
Clinical use of cancer biomarkers in epithelial ovarian cancer: updated guidelines from the European Group on Tumor Markers
…, SOA Hassan, RHM Verheijen, B Tholander… - International Journal of …, 2016 - ijgc.bmj.com
Objective To present an update of the European Group on Tumor Markers guidelines for
serum markers in epithelial ovarian cancer. Methods Systematic literature survey from 2008 …
serum markers in epithelial ovarian cancer. Methods Systematic literature survey from 2008 …
A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites
…, G Mangili, S Mammoliti, M Kalling, B Tholander… - Gynecologic …, 2012 - Elsevier
OBJECTIVE: The recombinant fusion protein, aflibercept binds and neutralizes vascular
endothelial growth factor (VEGF) A, B and placental growth factor (PlGF). Aflibercept inhibits …
endothelial growth factor (VEGF) A, B and placental growth factor (PlGF). Aflibercept inhibits …
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer–a Swedish Gynecologic Cancer …
…, J Marcickiewicz, P Rosenberg, B Tholander… - Acta …, 2019 - Taylor & Francis
Background: The aim of this study is to evaluate the impact of lymphovascular space
invasion (LVSI) on the risk of lymph node metastases and survival in endometrioid …
invasion (LVSI) on the risk of lymph node metastases and survival in endometrioid …
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma …
B Tholander, A Taube, A Lindgren, O Sjöberg… - Gynecologic …, 1990 - Elsevier
Pretreatment serum levels of the antigens CA-125, tissue polypeptide Antigen (TPA),
Carcinoembryonic antigen (CEA), and placental alkaline phosphatase (PLAP) were …
Carcinoembryonic antigen (CEA), and placental alkaline phosphatase (PLAP) were …
Data quality in the Swedish quality register of gynecologic cancer–a Swedish Gynecologic Cancer Group (SweGCG) study
…, E Hjerpe, E Holmberg, K Stålberg, B Tholander… - Acta …, 2018 - Taylor & Francis
Aim: The aim of this study is to evaluate the quality of data on endometrial (EC) and ovarian,
fallopian tube, peritoneal, abdominal or pelvic cancers (OC) registered in the Swedish …
fallopian tube, peritoneal, abdominal or pelvic cancers (OC) registered in the Swedish …
[HTML][HTML] Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer
A Gonzalez-Martin, L Gladieff, B Tholander… - European Journal of …, 2013 - Elsevier
Purpose The single-arm OCTAVIA study evaluated front-line bevacizumab plus weekly
paclitaxel and q3w carboplatin. Patients and methods Patients with newly diagnosed …
paclitaxel and q3w carboplatin. Patients and methods Patients with newly diagnosed …
Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer—A Swedish Gynecologic Cancer Group (SweGCG) study
…, P Kjølhede, P Rosenberg, B Tholander… - Acta Obstetricia et …, 2021 - Wiley Online Library
Introduction Deep myometrial invasion (≥ 50%) is a prognostic factor for lymph node
metastases and decreased survival in endometrial cancer. There is no consensus regarding …
metastases and decreased survival in endometrial cancer. There is no consensus regarding …
Risk factors for lymph node metastases in women with endometrial cancer: A population‐based, nation‐wide register study—On behalf of the Swedish Gynecological …
…, E Holmberg, C Staf, B Tholander… - … Journal of Cancer, 2017 - Wiley Online Library
The role of lymphadenectomy in the management of early endometrial cancer remains
controversial. In the recent ESMO‐ESGO‐ESTRO guidelines, lymphadenectomy is …
controversial. In the recent ESMO‐ESGO‐ESTRO guidelines, lymphadenectomy is …